GlaxoSmithKline Consumer Nigeria PLC 1 Industrial Avenue, Ilupeju

RC 8726

PMB 21218 Ikeja, Lagos

Tel: +234 (01) 2711000, (01) 3242900www.gsk.com/ng

Lagos, 25th March 2022

NOTICE OF SCHEDULED BOARD MEETING

This is to notify the General Public and Nigerian Exchange Limited (NGX), that the Board of Directors' meeting of GlaxoSmithKline Consumer Nigeria Plc (the Company) rescheduled to hold on Wednesday, 23rd March 2022 held as scheduled and the Board of directors approved:

  • 1. The Audited Financial Statements of GlaxoSmithKline Consumer Nigeria Plc for the financial year ended 31st December 2021

  • 2. The Dividends to be proposed to Shareholders at the Annual General Meeting

The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons earlier announced is still in place and will terminate 24 hours after the release of the approved Audited Financial Statements to the Market.

For: GlaxoSmithKline Consumer Nigeria PLC

Frederick Ichekwai

Company Secretary

Agbara Factory: Km 32, Igbesa Road, Agbara, Ogun State. Tel: +234 (01) 2918000.Email:Customer_ch_nigeria@gsk.com

Directors: Mr. Edmund Onuzo, Chairman; Mr. Kunle Oyelana, Managing Director; Mr. Samuel Kuye; Mr. Bosco Kirugi (Kenyan) Finance Director, Mr. Mark

Pfister (South Africa); Mrs. Oludewa Edodo-Thorpe; Mr. Oussama Abbas (French); Ms. Amina Salihu

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Glaxo Smithkline Consumer Nigeria plc published this content on 25 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2022 14:06:10 UTC.